GE HealthCare Technologies (NASDAQ:GEHC) Coverage Initiated by Analysts at Hovde Group

Hovde Group initiated coverage on shares of GE HealthCare Technologies (NASDAQ:GEHC) in a research report sent to investors on Friday morning,Benzinga reports. The brokerage issued a market perform rating and a $14.00 price objective on the stock.

GEHC has been the topic of a number of other research reports. Evercore set a $80.00 price target on GE HealthCare Technologies in a report on Thursday, April 30th. Oppenheimer reiterated an “outperform” rating and set a $85.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Citigroup reissued a “neutral” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. Wells Fargo & Company cut their price target on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Finally, The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Ten analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and a consensus price target of $76.41.

GE HealthCare Technologies Trading Down 4.0%

Shares of GE HealthCare Technologies stock opened at $63.07 on Friday. The firm has a market cap of $28.69 billion, a price-to-earnings ratio of 15.09, a price-to-earnings-growth ratio of 1.79 and a beta of 0.72. GE HealthCare Technologies has a 52-week low of $58.75 and a 52-week high of $89.77. The company’s 50-day simple moving average is $63.64 and its 200-day simple moving average is $71.96. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. During the same period in the prior year, the company earned $1.01 EPS. The company’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts anticipate that GE HealthCare Technologies will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.35%.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CFO James Saccaro acquired 3,310 shares of the firm’s stock in a transaction on Friday, May 1st. The stock was bought at an average cost of $60.60 per share, with a total value of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares in the company, valued at approximately $5,300,742.60. This represents a 3.93% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Peter J. Arduini bought 4,169 shares of the company’s stock in a transaction dated Thursday, April 30th. The shares were acquired at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the transaction, the chief executive officer owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders acquired 21,847 shares of company stock worth $1,361,355. 0.36% of the stock is currently owned by insiders.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of institutional investors have recently modified their holdings of GEHC. Laurel Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies during the fourth quarter valued at approximately $26,000. Optima Capital LLC acquired a new position in GE HealthCare Technologies in the fourth quarter worth $27,000. Godfrey Financial Associates Inc. acquired a new position in GE HealthCare Technologies in the fourth quarter worth $27,000. Montag A & Associates Inc. raised its holdings in shares of GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC grew its position in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.